Ron DeLyons

About Ron DeLyons

Independent director of Chemed Corporation since 2020; age 63. Managing Member and CEO of Creekwood Energy Partners, LLC (renewable energy) since 2004; previously co‑founder and CEO of Greystone Investment Management. Completed Berkeley Law Executive Education certificate “ESG: Navigating the Board’s Role” in April 2021. Determined independent under NYSE listing standards.

Past Roles

Organization	Role	Tenure	Committees/Impact
Greystone Investment Management	Co‑founder & Chief Executive Officer	Not disclosed	Investment management leadership background

External Roles

Organization	Type	Role	Tenure	Notes
Creekwood Energy Partners, LLC	Private (renewable energy)	Managing Member & Chief Executive Officer	Since 2004	Industry operator experience

Board Governance

Committee membership: Audit Committee member; not designated as the Audit Committee Financial Expert (asterisk denotes experts for Grace, Rice, Mount). Audit Committee met 7 times in 2024.
Independence: Board affirmatively determined Mr. DeLyons is independent (NYSE standards).
Attendance: In 2024, all directors attended at least 80% of Board and applicable Committee meetings; Mr. DeLyons attended the May 20, 2024 Annual Meeting (exceptions were Hutton and Heaney).
Leadership and process: Board holds executive sessions at scheduled meetings; Chairman George J. Walsh III presides. Roles of CEO and Chairman are separated (Walsh is Chairman).
Majority voting and resignation policy in uncontested elections; incumbents submit contingent resignations if not receiving majority of votes cast.

Fixed Compensation

Component	Company Policy/Rate	Ron DeLyons – 2024
Annual Board retainer (cash)	$80,000 per non‑employee director	Included in cash fees
Board meeting fee	$3,000 per Board meeting	Included in cash fees
Audit Committee membership fee	$15,000 per member (Chair $30,000)	Included in cash fees
Committee meeting fee	$1,000 per meeting ($500 if same day as Board meeting)	Included in cash fees
Chairman of the Board fee	$145,000 (not applicable to DeLyons)	N/A
Annual equity grant (fully vested)	May 2024 grant of 284 shares to each non‑employee director; approximately $160,273 value	Stock awards: $166,273 (includes $6,000 Director Deferred Compensation stock credit)
Director Deferred Compensation Plan	$6,000 credited per year; invested in Company stock; dividends reinvested	$6,000 credited in 2024
Total cash fees (2024)	Structure as above	$115,500
Total director compensation (2024)	Cash + equity + other	$281,773

Performance Compensation

Item	Disclosure for Directors	Detail
Performance metrics tied to director pay	None disclosed	Non‑employee director equity grants are fully vested stock awards; no PSU/option metrics apply to directors

Other Directorships & Interlocks

Organization	Type	Role	Public Company?	Interlock/Committee Notes
Creekwood Energy Partners, LLC	Private	Managing Member & CEO	No	N/A
Other public company boards	—	None disclosed	—	No compensation committee interlocks reported for Chemed’s Compensation Committee in 2024

Expertise & Qualifications

Operating CEO experience (renewable energy) and prior investment management CEO background.
ESG board education credential (Berkeley Law Executive Education, April 2021).
Audit Committee service; not designated as “financial expert.”

Equity Ownership

Item	Value
Beneficial ownership (Dec 31, 2024)	1,389 shares
Options held	0 (none exercisable disclosed)
Ownership as % of class	Under 1% (percentages under 1.0% not shown)
Approximate market value of holdings (Dec 31, 2024)	$736,282, using $529.80 closing price × 1,389 shares
Director stock ownership guideline	Required to retain $400,000 (5× $80,000 retainer)
Guideline compliance disclosure	Company states all directors/executives have met guidelines or are pursuing plans to achieve them within allotted timeframe
Anti‑hedging policy	Officers and directors prohibited from hedging Company stock

Governance Assessment

Positives: Independent director with Audit Committee membership; Board uses majority voting with contingent resignations; clear separation of Chair/CEO; adopted NYSE‑compliant clawback policy and anti‑hedging policy; structured director pay balanced between cash retainer/meeting fees and fully vested equity; robust ERM oversight through Audit; Say‑on‑Pay support at 82.70% in 2024, indicating investor alignment.
Attendance and engagement: Met at least 80% threshold for Board/Committee meetings in 2024; attended 2024 Annual Meeting.
Conflicts/related‑party exposure: No related‑party transactions disclosed involving Mr. DeLyons; Section 16 filings—only Ms. Lindell had a late filing in 2024 (no issue noted for DeLyons).
Watch items: Not designated as Audit Committee Financial Expert (others on Audit are so designated); continue monitoring any external business ties for potential conflicts, though none are disclosed.